Letter: Treating TB
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Sir: The way Giles O'Bryen caught TB ("I still have no idea how I caught TB", 9 December) probably has something to do with the ease and frequency of international travel these days, breaking down the boundaries between Europe and those Third World countries where TB is endemic.
Mr O'Bryen was lucky that he caught a treatable form of the disease. Increasingly, on account of the failure of patients to complete their courses of treatment, multidrug-resistant strains are appearing, requiring much longer and more expensive treatment. As 95 per cent of patients are in developing countries which cannot afford such courses, TB is well on the way to becoming virtually untreatable, and it isn't going to stay "over there". In a few years' time, Mr O'Bryen's case may not be a one- off curiosity.
The World Health Organisation's new DOTS strategy (Directly Observed Treatment Short-course) has been achieving success rates of up to 93 per cent. The world needs to get behind this, quickly.
BILL LINTON
London N13
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments